A 62-Year-Old Female with Stage IV BRAF-Mutated Melanoma

Source: Targeted Oncology, December 2023

Michael B Atkins, MD, discusses first-line treatment options for a patient with stage IV BRAF-mutated melanoma. He also reviews data that may help guide treatment and sequencing decisions for patients with metastatic melanoma.
READ THE ORIGINAL FULL ARTICLE